Test Price
2,800 AED✅ Home Collection Available
NUBPL Gene Leigh Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain & VIP Mobile Phlebotomy – 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post‑Test Interpretation with DHA‑Licensed Specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS‑based genetic test comprehensively sequences the NUBPL gene to diagnose Leigh syndrome, a severe neurodegenerative mitochondrial disorder. Next‑Generation Sequencing ensures full gene coverage and detection of novel variants that traditional methods may miss.
| Parameter | Our NGS Test (ISO 9001) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity – full gene coverage | Limited to known hotspots; may miss novel variants |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing |
| Turnaround Time | 3–4 Weeks | 3–5 Weeks |
Physician Insight & Safety Protocols
"As a DHA‑licensed Consultant Medical Genetics (License 9294403), I emphasize that genetic testing for Leigh syndrome must always be correlated with clinical findings and a detailed family history. Confirmatory testing and genetic counseling are essential for accurate interpretation."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics
Advisory & Pre-Test Considerations
- Informed Consent: Written consent must be obtained per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Insurance Verification: Submit your insurance card via WhatsApp +971 54 548 8731 for direct billing confirmation.
- Pediatric Testing: Minors require parental consent and pre‑test genetic counseling provided by our licensed specialists.
Exclusion Criteria & Red Flags
- Exclusion: Active severe infection, bleeding disorders, or inability to provide informed consent.
- Exclusion: Recent blood transfusion (<3 months) – may interfere with DNA analysis.
- Emergency Red Flags: If the patient experiences acute neurological decline, unprovoked seizures, respiratory distress, or sudden vision loss, seek emergency medical care immediately – do not wait for test completion.
- Medication Notice: Do not alter or discontinue any prescribed therapy without consulting your treating physician.
Patient FAQ & Clinical Guidance
1. What is the purpose of the NUBPL gene test?
The NUBPL gene test detects inherited mutations responsible for Leigh syndrome, a rare mitochondrial disease, enabling precise diagnosis and genetic counseling. Accurate identification of pathogenic variants guides clinical management and family planning.
2. How is the sample collected and what preparation is required?
A simple blood draw (3–5 mL) or dried blood spot is collected by a certified phlebotomist. No fasting is generally required. Our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM, with temperature-controlled cold-chain transport to the laboratory.
3. Can this test be used for children, and what legal consents apply?
Yes, pediatric testing is permitted. The parent or legal guardian must provide signed informed consent in accordance with Federal Decree‑Law No. 4 of 2016. Pre‑test genetic counseling with a DHA‑licensed specialist is mandatory for minors.
4. How long does it take to get results, and how will I receive them?
Turnaround time is 3–4 weeks from sample receipt. Results are delivered via secure electronic report and discussed during a telephonic consultation with a genetic specialist.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
- Personal Data Protection: Your health information is processed in strict adherence to Federal Decree‑Law No. 45 of 2021 (PDPL).
- Health Data Governance: Compliant with Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields.
- Medical Liability & Consent: All genetic testing procedures incorporate informed consent as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Accreditation: ISO 9001:2015 certified (INT/EGQ/2509DA/3139) and fully licensed by the Dubai Health Authority (DHA).
Clinical & Logistical Metadata
| Test Name | NUBPL Gene Sequencing – Leigh Syndrome Panel |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Blood (3–5 mL) or Dried Blood Spot – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage, 99.9% sensitivity |
| ICD-10-CM Code | G31.82 (Leigh Syndrome) |
| LOINC Code | 69261-4 (Genetic testing for inherited mitochondrial disorder) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians